LA JOLLA, CA—A discovery by scientists at the Salk Institute for Biological Studies might explain why some premature infants fail to respond to existing treatments for a deadly respiratory distress syndrome (RDS) and offers clues for new ways to treat the breathing disorder.
LA JOLLA, CA—The SCImago Institutions Rankings (SIR) World Report has identified the Salk Institute as one of the top five research organizations in the world, based on excellence and high quality of its scientific findings.
LA JOLLA—The National Institutes of Health has announced that the Salk Institute will receive $4.5 million to establish a Neuroscience Core Center, a new research center intended to accelerate brain research that lays the foundation for developing new ways to treat congenital brain defects and neurological diseases.
LA JOLLA, CA‚Ever wondered why you wake up in the morning—even when the alarm clock isn’t making jarring noises? Wonder no more. Researchers at the Salk Institute for Biological Studies have identified a new component of the biological clock, a gene responsible for starting the clock from its restful state every morning.
LA JOLLA, CA—Dr. Fred Gage, a professor in the Salk Institute Laboratory of Genetics and holder of the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Diseases, has been named a 2011 recipient of the prestigious National Institutes of Health (NIH) Director’s Transformative Research Projects (T-R01) program.
LA JOLLA, CA—Researchers at the Salk Institute have discovered how a hormone turns on a series of molecular switches inside the pancreas that increases production of insulin.
La Jolla—A strain of genetically enhanced bacteria developed by researchers at the Salk Institute for Biological Studies may pave the way for new synthetic drugs and new ways of manufacturing medicines and biofuels, according to a paper published September 18 in Nature Chemical Biology.
LA JOLLA, CA—Axel Nimmerjahn, Ph.D., assistant professor in the Waitt Advanced Biophotonics Center and holder of the Richard Allan Barry Developmental Chair in Biophotonics has been awarded a highly selective grant from the Whitehall Foundation. He will receive $223,000.00 over three years to study the contribution of astrocytes to normal brain function.
LA JOLLA, CA—A “hidden” code linked to the DNA of plants allows them to develop and pass down new biological traits far more rapidly than previously thought, according to the findings of a groundbreaking study by researchers at the Salk Institute for Biological Studies.
LA JOLLA, CA—Oncologists have long sought a powerful “magic bullet” that can find tumors wherever they hide in the body so that they can be imaged and then destroyed. Until recently scientists accepted the notion that such an agent, an agonist, needed to enter and accumulate in the cancerous cells to act. An international research team has now shown in cancer patients that an investigational agent that sticks onto the surface of tumor cells without triggering internalization, an antagonist, may be safer and even more effective than agonists.
LA JOLLA, CA—More than 230,000 women in United States will be diagnosed with breast cancer this year, of which nearly 10% will have mutations in either BRCA1 or 2 genes. The BRCA1 gene and its protein are known to play a powerful role in preventing breast and ovarian cancer development, but just how it does this has long been a debated, even controversial, topic. Now, in the September 8th issue of Nature, researchers at the Salk Institute may have found an answer—and it suggests the differing prevailing theories up to now were all a little bit right.
LA JOLLA, CA—If you think today’s political rhetoric is overheated, imagine what goes on inside a vertebrate embryo. There, two armies whose agendas are poles apart, engage in a battle with consequences much more dire than whether the economy will recover—they are battling for whether you (or frogs or chickens) will have a forebrain.
Perched high above the Pacific Ocean, under a canopy of stars, the iconic courtyard was transformed into an enchanting concert venue for the 16th annual Symphony at Salk.
LA JOLLA, CA—The Salk Institute for Biological Studies today announced a generous $1.6 million dollar gift from the estate of Henry and Lottie O’Neal of Anchorage, Alaska. Their substantial donation will help continue the pioneering research conducted at the Salk Institute.
LA JOLLA, CA—Thomson Reuters Essential Science Indicators has seeded the Salk Institute as the number one research organization for plant biology in the world.
La Jolla—Our next generation of Scientists have arrived. Salk’s high school scholars – students from around San Diego County – gather at the Institute every summer to participate in hands-on laboratory experiences under the mentorship of a Salk scientist. The young scientists will present their findings today during the “Summer Research Presentations” event at 1:00 pm in the Trustees Room at the Salk Institute.
La Jolla—Science usually progresses in small steps, but on rare occasions, a new combination of research expertise and cutting-edge technology produces a ‘great leap forward.’ An international team of scientists, whose senior investigators include Salk Institute plant biologist Joseph Ecker, report one such leap in the July 29, 2011 issue of Science. They describe their mapping and early analyses of thousands of protein-to-protein interactions within the cells of Arabidopsis thaliana -a variety of mustard plant that is to plant biology what the lab mouse is to human biology.
LA JOLLA, CA—Drug developers have long been looking for agents that will target a cell receptor that regulates stress in humans, but no small molecule drugs have successfully gone through clinical studies. Now, a team at the Salk Institute has demonstrated how a novel tool can be used to map the binding sites on this receptor, which they say could speed the design of effective therapies.
LA JOLLA, CA—Scientists at the Salk Institute for Biological Studies have developed an improved technique for generating large numbers of blood cells from a patient’s own cells. The new technique will be immediately useful in further stem cell studies, and when perfected, could be used in stem cell therapies for a wide variety of conditions including cancers and immune ailments.
LA JOLLA, CA—Ipsen and the Salk Institute for Biological Studies announced today that they are renewing the Ipsen Life Sciences Program at the Salk Institute. The mission of the partnership is to advance knowledge in the field of proliferative and degenerative diseases through fundamental and applied biology research.
Your partnership allows our scientists to accelerate the pace of high-risk, high-reward discoveries that have the potential to benefit the health of all humanity-be it cancer, Alzheimer’s disease, climate change, infectious diseases or more.
